Celiac disease is an autoimmune disorder that can induce a variety of digestive symptoms such as nausea, chronic diarrhea, vomiting and stomach pain. Reportedly, the prevalence of this disease is approximately three times higher among individuals with cystic fibrosis. Recent research indicated that cystic fibrosis transmembrane conductance regulator (CFTR) is a molecular target for gluten that contributes to the pathogenesis of celiac disease.
Hence, CFTR potentiators involved in the treatment of cystic fibrosis may also prevent celiac disease. Source: Medical news today
